Inventor · disambiguated record
Morten Jørgensen
Also filed as: JOERGENSEN MORTEN · JØRGENSEN MORTEN · JØRGENSEN MORTEN EGEVANG
14 granted patents·6 pending applications·77 citations·filing 2010–2025
90Inventor score
Top patents by PatentIndex Score
20 records- 0198US11707476B2Catecholamine prodrugs for use in the treatment of parkinson's diseaseH LUNDBECK AS·Filed 2021·Granted Jul 25, 2023·12 cites·17 claims
- 0298US11110110B2Catecholamine prodrugs for use in the treatment of Parkinson's diseaseH LUNDBECK AS·Filed 2020·Granted Sep 7, 2021·15 cites·20 claims
- 0397US12226428B2Catecholamine prodrugs for use in the treatment of Parkinson's diseaseH LUNDBECK AS·Filed 2023·Granted Feb 18, 2025·6 cites·22 claims
- 0497US10729710B2Catecholamine prodrugs for use in the treatment of Parkinson's diseaseH LUNDBECK AS·Filed 2018·Granted Aug 4, 2020·21 cites·15 claims
- 0596US11858954B2Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acidH LUNDBECK AS·Filed 2021·Granted Jan 2, 2024·8 cites·31 claims
- 0696US11130775B2Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acidH LUNDBECK AS·Filed 2020·Granted Sep 28, 2021·14 cites·16 claims
- 0783US12421271B2Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR, 10AR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acidH LUNDBECK AS·Filed 2023·Granted Sep 23, 2025·0 cites·23 claims
- 0876US11535600B2Prodrugs of 4-((1R,3S)-6-chloro-3-phenyl-2,3-dihydro-1H-inden-1-yl)-1,2,2-trimethylpiperazine and 4-((1R,3S)-6-chloro-3-(phenyl-d5)-2,3-dihydro-1H-inden-1-yl)-2,2-dimethyl-1-(methyl-d3)piperazineH LUNDBECK AS·Filed 2019·Granted Dec 27, 2022·1 cites·15 claims
- 0973US12071416B2Prodrugs of 4-( (1R, 3S)-6-chloro-3-phenyl-2, 3-dihydro-1H-inden-1-yl)-1,2, 2-trimethylpiperazine and 4-( (1R, 3S)-6-chloro-3-(phenyl-D5)-2, 3-dihydro-1H-inden-1-yl)-2, 2-dimethyl-1 (methyl-D3) piperazineH LUNDBECK AS·Filed 2022·Granted Aug 27, 2024·0 cites·13 claims
- 1073US2025381208A1Catecholamine prodrugs for use in the treatment of parkinson’s diseaseH LUNDBECK AS·Filed 2025·Application pending·0 cites
- 1159US2016083359A11-[2-(2,4-DIMETHYLPHENYLSULFANYL)-PHENYL]PIPERAZINE AS A COMPOUND With COMBINED SEROTONIN REUPTAKE, 5-HT3 AND 5-HT1A ACTIVITY FOR THE TREATMENT OF COGNITIVE IMPAIRMENTLUNDBECK & CO AS H·Filed 2015·Application pending·0 cites
- 1255US12391650B2Catecholamine prodrugs for use in the treatment of Parkinson's diseaseH LUNDBECK AS·Filed 2020·Granted Aug 19, 2025·0 cites·23 claims
- 1353US12384765B2Catecholamine prodrugs for use in the treatment of Parkinson's DiseaseH LUNDBECK AS·Filed 2020·Granted Aug 12, 2025·0 cites·27 claims
- 1451US12319710B2Catecholamine prodrugs for use in the treatment of Parkinson's diseasesH LUNDBECK AS·Filed 2020·Granted Jun 3, 2025·0 cites·29 claims
- 1551US2024025857A1New catecholamine prodrugs for use in the treatment of parkinson's diseaseH LUNDBECK AS·Filed 2021·Application pending·0 cites
- 1644US12398106B2Catecholamine carbamate prodrugs for use in the treatment of parkinson's diseaseH LUNDBECK AS·Filed 2020·Granted Aug 26, 2025·0 cites·24 claims
- 1744US11583098B2Pocket spring coreL&P SWISS HOLDING GMBH·Filed 2019·Granted Feb 21, 2023·0 cites·16 claims
- 1838US2014137294A1Glucosinolate transporter protein and uses thereofDENOLF PETER·Filed 2011·Application pending·0 cites
- 1937US2020178698A1Pocketed spring unit having multiple inner springsL&P SWISS HOLDING GMBH·Filed 2018·Application pending·0 cites
- 2035US2012108624A1Treatment of dyskinesia related disordersWIKSTROEM HAAKAN·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Morten Jørgensen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →